Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

J-P Courrèges, Tina Vilsbøll, M Zdravkovic, Xuan Le Thi Thanh, T Krarup, Ole Schmitz, R Verhoeven, I Bugáñová, S Madsbad

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

178 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftDiabetic Medicine
Vol/bind25
Udgave nummer9
Sider (fra-til)1129-31
Antal sider3
ISSN0742-3071
DOI
StatusUdgivet - 1 sep. 2008

Citationsformater